Indicators of Therapeutic Response in Rheumatoid Arthritis: Transitioning from Traditional Markers to Tissue Immunophenotyping
-
By
-
N.A. Batashkov
-
E.V. Gerasimova
-
D.A. Gerasimova
-
D.V. Svetlichnyy
-
E.S. Petryakina
-
D.I. Tychinin
-
S.M. Yudin
-
V.S. Yudin
-
A.A. Keskinov
-
V.P. Bogdanov
-
E.G. Zotkin
-
A.M. Lila
-
D.V. Tabakov
-
M. Woroncow
-
V.I. Skvortsova
-
P.Yu Volchkov
-
July 17, 2026
Clinical Scorecard: Indicators of Therapeutic Response in Rheumatoid Arthritis: Transitioning from Traditional Markers to Tissue Immunophenotyping
At a Glance
| Category | Detail |
|---|
| Condition | Rheumatoid Arthritis |
| Key Mechanisms | Biological heterogeneity, immune-mediated inflammation, synovial pathotypes |
| Target Population | Adults, particularly those over 40 years old, with a higher prevalence in women |
| Care Setting | Clinical management of rheumatoid arthritis |
Key Highlights
- RA is characterized by substantial variability in therapeutic response.
- Current treatment strategies often lack reliable predictive biomarkers.
- Emerging biomarkers include synovial pathotypes and immune cell profiling.
- Approximately 30-40% of patients do not respond adequately to first-line therapy.
- Recent advances in molecular technologies enhance characterization of RA.
Guideline-Based Recommendations
Diagnosis
- Utilize clinical, serological, and imaging biomarkers for diagnosis.
Management
- First-line therapy includes conventional synthetic DMARDs, primarily methotrexate.
Monitoring & Follow-up
- Monitor treatment response and adjust therapy based on clinical outcomes.
Risks
- Prolonged inflammation may lead to irreversible joint damage.
Patient & Prescribing Data
Patients with rheumatoid arthritis, particularly those with inadequate response to initial therapies.
Therapy escalation to biologic DMARDs or targeted synthetic DMARDs may be necessary for non-responders.
Clinical Best Practices
- Integrate conventional and emerging biomarkers for precision medicine.
- Consider the biological heterogeneity of RA when selecting treatment.
Related Resources & Content
